Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @chaperonycon
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @chaperonycon
-
Die Bundesregierung hat keinen breit angelegten Notfallplan gg eine
#coronavirus Epidemie aufgestellt. Schulen, KiTas, TV müßten Desinfektionshinweise geben. Ärzte zu richtiger Diagnose geschult, Apotheken mit Atemschutzmasken bevorratet werden.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
With the sales growth seen so far and the likely addition of a Remicade biosimilar, Bernstein analyst Ronny Gal said "it's tough to see " Amgen 2020 biosimilar sales of less than $1.8 billion, up from $570 million in 2019.
#biosimilarshttps://www.biopharmadive.com/news/amgen-pfizer-biosimilar-growth-herceptin-avastin/571502/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
„Severin Schwan geht dieses Jahr von rund vier Milliarden Franken Umsatzeinbußen durch sogenannte Biosimilars aus nach etwa 1,5 Milliarden Franken 2019.“
#biosimilarshttps://twitter.com/MrElnurHuseynov/status/1223216985066131456 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SpeedyGonzalesi proslijedio/la je Tweet
The ‘benefit:risk grid’ from my recent talk on Positioning Therapies. We’re still missing an agent for the top left..pic.twitter.com/cw9Ccf0rj7
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SpeedyGonzalesi proslijedio/la je Tweet
Und weiter mit den schlechten Nachrichten zu
#nCoV19 : Wissenschaftler der Universität Hong Kong gehen davon aus, dass die Situation in#Wuhan außer Kontrolle ist und in vielen weiteren chinesischen Großstädten binnen 14 Tagen eskalieren könnte.#coronavirushttps://twitter.com/ScottGottliebMD/status/1223269418211389442 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SpeedyGonzalesi proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
SpeedyGonzalesi proslijedio/la je Tweet
Humira biosimilars now controlling almost 40% of the market in the EU, according to Bernstein. The UK and Germany are outpacing the others... ...and the US looks on in shame, swallowing another 7.4% price increase from AbbVie for 2020pic.twitter.com/zUjbFNQhoa
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
And in Q2 clinical sites in US start recruiting PH2b UC. A financing plan therefore should be prooved. Wished speed in recruitment will make some costs
$abvxhttps://twitter.com/GermanBiotech/status/1222067124686000128 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
"Roughly 80% of active ingredients used by commercial sources to produce finished medicines come from China, Christopher Priest, deputy assistant director at the U.S. Defense Health Agency"https://twitter.com/pharmalot/status/1221810344445784067 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
SpeedyGonzalesi proslijedio/la je TweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
The promotion by forbes and der aktionär are imo small hints for a capital increase. Why searching the public when we are shortly before a big deal?
$abvxhttps://twitter.com/GermanBiotech/status/1220427490486820864 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
22-24% price discount is for the moment quite moderate. The question is however, what are the discounts mediated in the backroom.
#biosimilarshttps://twitter.com/josh_whitehill/status/1220427460140990464 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Nice wants more dicount for recommendation of
#stelara in GB (ulcerative colitis)https://twitter.com/PharmaTimes/status/1220287704329596928 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
change of reimbursement conditions is a key to success for costs of healthcare and
#biosimilars producers.https://twitter.com/profitechconsu1/status/1219815480422096896 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Perhaps abivax has used a specific preclinical murine model for crohn`s, to get some light in this indication. (No DSS) https://www.ncbi.nlm.nih.gov/pubmed/28560286 https://twitter.com/GermanBiotech/status/1219375883863109632 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Korean biosimilar developers belong to the top of the world. S.c. infliximab was a valuable development.
#biosimilarshttps://twitter.com/Dominic_Tyer/status/1218851848976814082 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Both alpha integrin mabs have a convincing security profile in contrast to anti TNFalpha-mabs.
#ulcerativecolitis#IBDhttps://twitter.com/AntibodyNews/status/1218622472100036608 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Be aware of the quality of products, compounding pharmacies with beva portioning have problems with aseptic deliverage, particle-free prod., risk of off label use for physicians. Prefilled syringe could be the key to success. Bioeq and formycon do have the edge here.
#biosimilarshttps://twitter.com/larrywabrams/status/1218269457564323841 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
But the coherus strategy is successfull mainly with indications with limited decision-makers. Salesforce can so be limited. Look at the JPM2020 slides. Big indications like RA, allergic reactions, psoriasis are more difficult to distribute economically.
#biosimilarshttps://twitter.com/larrywabrams/status/1218298464263491584 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
2020 goals are accomplishing the Phase 3 trial with xlucane and finding a US distribution partner.
#biosimilarshttps://twitter.com/proactive_UK/status/1217488628659650563 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.